Regenics vs LTTL: Compounded GLP-1 pricing, care, and pharmacy differences
Quick verdict: For lower promotional entry pricing and a Sermorelin add-on, Regenics is the clearer cash-pay option; LTTL emphasizes an auto-applied first-month code and compound verification. Regenics vs LTTL centers on promotional first-month pricing, clinician model, pharmacy verification, medication lineup, and renewal transparency.
Start Regenics—see semaglutide $139 first month
How Regenics vs LTTL compare at a glance
This comparison uses only the supplied facts. Both offer telehealth clinician review and compounded GLP-1 medications prepared by U.S. licensed pharmacies. Key differences are promotional first-month pricing, clinician type and extras, how pharmacy verification is described, and clarity about renewal pricing.
Early verdict repeated
Regenics provides lower advertised first-month prices for semaglutide and tirzepatide and includes a Sermorelin peptide option; LTTL emphasizes an up to $140 off first month code and laboratory verification claims.
Side by side: the most distinctive differences
| Criteria | Regenics | LTTL |
|---|---|---|
| Starting price | Semaglutide $139 first month; tirzepatide $189 first month | Advertises up to $140 off first month; pricing details not verified |
| Pricing model | Promotional first month, then renewals (semaglutide renews $199/mo; tirzepatide $279/mo) | Code auto-applied for first month; current details not published or verified |
| Medications offered | Compounded semaglutide and tirzepatide plus Sermorelin peptide | Compounded GLP-1 medications; full-dose GLP-1 promoted |
| Clinician oversight | Licensed nurse practitioners review intake before prescription | Treatment available only when a licensed clinician determines it is medically appropriate |
| Pharmacy and verification | Prepared by U.S. licensed compounding pharmacies; pharmacy network LegitScript certified | Prepared in state-licensed pharmacies; claims of independent verification in FDA registered labs and periodic strength confirmation |
| Regulatory note | Compounded medications are not FDA-approved finished products | Compounded medications are not FDA-approved and are not reviewed by FDA |
Compare Regenics plans and Sermorelin option
Pricing and renewal transparency
Regenics specifies promotional first-month prices for semaglutide and tirzepatide and notes renewals at higher monthly rates. The Regenics evidence states promotional pricing applies to the first month only and lists renewal amounts. LTTL promotes up to $140 off your first month with a code auto-applied, but captured details say current pricing, eligibility and renewal terms were not published or could not be verified on the captured page.
Clinician model and program features
Regenics is described as nurse-practitioner-led care with licensed nurse practitioners overseeing every prescription and clinician review before prescribing. LTTL indicates treatment is available only when a licensed clinician determines it is medically appropriate. Regenics specifically lists a Sermorelin peptide therapy add-on; LTTL focuses on full-dose GLP-1 offerings in its captured content.
Check LTTL eligibility and first-month code
Pharmacy processing and quality claims
Both providers reference U.S. licensed compounding pharmacies. Regenics notes its pharmacy network is LegitScript certified and that medications are compounded in the USA. LTTL states medications are prepared in state-licensed pharmacies and claims independent verification in FDA registered labs and periodic confirmation of strength every 3 to 6 months to stay within plus or minus 10 percent of target strength. These are captured claims and are presented as stated by each provider.
Safety and regulatory language
Both sources include the regulatory caution that compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. Regenics additionally frames that treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications are not FDA-approved.
View LTTL verification and lab claims
Conclusion: Choose based on what matters most
Regenics vs LTTL comes down to clear first-month promotional pricing and a named peptide add-on versus an advertised auto-applied first-month code and specific lab verification claims. Choose Regenics if you want advertised lower promotional entry pricing for semaglutide or tirzepatide, nurse-practitioner-led telehealth care, and a Sermorelin option. Choose LTTL if you prioritize the captured claims of independent verification in FDA registered labs and an auto-applied up to $140 off first-month code, while confirming current pricing, eligibility and renewal terms before enrolling.
Choose Regenics if you want lower first-month pricing and a peptide add-on